West Pharmaceutical Services, Inc. (LON:0ADY)

Market Cap	16.32B +41.0%
Revenue (ttm)	2.44B +11.2%
Net Income	410.99M +16.2%
EPS	5.67 +17.4%
Shares Out	n/a
PE Ratio	39.72
Forward PE	35.46
Dividend	0.65 (0.20%)
Ex-Dividend Date	Apr 29, 2026

Volume	113
Average Volume	193
Open	327.46
Previous Close	n/a
Day's Range	327.46 - 327.46
52-Week Range	206.56 - 327.46
Beta	n/a
RSI	73.18
Earnings Date	Apr 23, 2026

About LON:0ADY

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Fabricated Rubber Products, Not Elsewhere Classified
• Founded: 1923
• Employees: 10,800
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0ADY

Financial Performance

In 2025, LON:0ADY's revenue was $3.07 billion, an increase of 6.25% compared to the previous year's $2.89 billion. Earnings were $493.70 million, an increase of 0.20%.

Financial numbers in USD